Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2007 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | 3,612 | 10,364 | 5,810 |
| Depreciation Amortization | 2,146 | 10,049 | 6,756 |
| Income taxes - deferred | -128 | 405 | 2,002 |
| Accounts receivable | -616 | -5,454 | -2,888 |
| Other Working Capital | -9,993 | 434 | -1,897 |
| Other Operating Activity | -2,954 | -3,062 | -1,859 |
| Operating Cash Flow | $-7,933 | $12,736 | $7,924 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -33,143 | -80,803 | -14,241 |
| Sale Of Investment | 24,908 | 67,912 | 40,127 |
| Other Investing Activity | 826 | 2,959 | 2,032 |
| Investing Cash Flow | $-7,409 | $-9,932 | $27,918 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 26,000 | 124,890 | 18,000 |
| Debt Repayment | N/A | N/A | -474 |
| Other Financing Activity | -23,250 | -130,994 | -39,365 |
| Financing Cash Flow | $2,750 | $-6,104 | $-21,839 |
| Exchange Rate Effect | 8 | -4 | 82 |
| Beginning Cash Position | 20,359 | 7,573 | 7,573 |
| End Cash Position | 7,775 | 4,269 | 21,658 |
| Net Cash Flow | $-12,584 | $-3,304 | $14,085 |
| Free Cash Flow | |||
| Operating Cash Flow | -7,933 | 12,736 | 7,924 |
| Capital Expenditure | -37,259 | -89,486 | -19,648 |
| Free Cash Flow | -45,192 | -76,750 | -11,724 |